Outlook Therapeutics Inc
F:41O
Outlook Therapeutics Inc
F:41O
Price:
0.63
EUR
-6.04%
Market Closed
Market Cap:
€28m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Outlook Therapeutics Inc
F:41O
|
US |
|
Telenor ASA
F:TEQA
|
NO |
|
A
|
American States Water Co
XMUN:FDK
|
US |
|
Precision BioSciences Inc
F:PBS0
|
US |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
41O Price Targets Summary
Outlook Therapeutics Inc
Outlook Therapeutics Inc
Wall Street analysts forecast 41O stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 41O is 3.8 EUR with a low forecast of 0.45 EUR and a high forecast of 5.63 EUR.
Lowest Forecast
Price Target
0.45
EUR
28% Downside
Average Forecast
Price Target
3.8
EUR
503% Upside
Highest Forecast
Price Target
5.63
EUR
794% Upside
Outlook Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41O's stock price target?
Price Target
3.8
EUR
3.8
EUR
According to Wall Street analysts, the average 1-year price target for 41O is 3.8 EUR with a low forecast of 0.45 EUR and a high forecast of 5.63 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
